Anti-CD74 IGA antibodies, genetic polymorphisms and inflammatory activity in ankylosing spondylitis
IgA anti-CD74 can be a promising marker for diagnosis, assessment of activity and prognosis for ankylosing spondylitis.The aim of the study was to determine the level of IgA anti-CD74 in patients with ankylosing spondylitis and to evaluate its relationships with ankylosing spondylitis activity and c...
Main Authors: | V. I. Mazurov, I. Z. Gaydukova, E. A. Vasilenko, S. V. Lapin, I. V. Kholopova, M. A. Korolev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2021-01-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/2963 |
Similar Items
-
Long-term efficacy and safety of netakimab in the treatment of ankylosing spondylitis: results of Phase III international, multicenter, randomized double-blind clinical trial BCD-085-5/ASTERA
by: V. I. Mazurov, et al.
Published: (2020-11-01) -
CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS
by: O. A. Rumyantseva, et al.
Published: (2018-05-01) -
Ankylosing spondylitis and non-radiographic axial spondyloarthritis: Two stages of disease?
by: D G Rumyantseva, et al.
Published: (2017-05-01) -
IL-23 Inhibition in Ankylosing Spondylitis: Where Did It Go Wrong?
by: Dominique Baeten, et al.
Published: (2021-02-01) -
Specific features of axial spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, in persons of different genders
by: A. P. Rebrov, et al.
Published: (2015-03-01)